… people receiving candidate COVID-19 vaccines to understand … for prioritizing among the
COVID-19 vaccine candidates with … enhanced severity of COVID-19 disease, after vaccination. …

… the outbreak of novel coronavirus erupted and then world-… COVID-19 vaccine before
September, 2020 as per very optimistic estimates. This is because a successful COVID-19 vaccine …

… genetic engineering procedures are required to obtain a COVID‑19 vaccine. The most difficult
scientific challenge for this future vaccine obtained in the laboratory is the proof of clinical …

… in Data COVID-19 vaccination dataset, a global public dataset that tracks the scale and rate
of the vaccine rollout … They are updated daily in sync with updates in our GitHub repository. …

… against COVID-19, currently, there is not any approved medication (drugs or vaccines) …
gives a sneak peek of recent updates on the development of COVID-19 vaccine worldwide. …

… nucleic acid vaccines. By mid-2021 three billion doses of COVID-19 vaccine have been
administered around the world, mostly in high-income countries. COVID-19 vaccination provides …

… , and vaccine registry databases. We assessed vaccine effectiveness against Covid-19
from May 1 through September 3, 2021, and against hospitalization with Covid-19 from May …

… COVID-19 vaccine; 2) unemployed participants reported lower influenza uptake and lower
COVID-19 vaccine … lower influenza vaccine uptake and lower COVID-19 vaccine acceptance …

… the most promising vaccine candidates. COVID-19 vaccine R&D landscape As of 8 April
2020, the global COVID-19 vaccine R&D landscape includes 115 vaccine candidates (Fig. 1), of …

… of the COVID-19 pandemic is driving evaluation of nextgeneration vaccine technology
platforms through novel paradigms to accelerate development, and the first COVID-19 vaccine …